300 related articles for article (PubMed ID: 31819426)
1. The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
Jiang Y; Liu C; Zhai W; Zhuang N; Han T; Ding Z
Int J Nanomedicine; 2019; 14():9217-9234. PubMed ID: 31819426
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability.
Jiang Y; Jiang Y; Ding Z; Yu Q
Int J Nanomedicine; 2022; 17():3443-3456. PubMed ID: 35959279
[TBL] [Abstract][Full Text] [Related]
4. Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery.
Wu Y; Zhang B; Kebebe D; Guo L; Guo H; Li N; Pi J; Qi D; Guo P; Liu Z
Pharm Dev Technol; 2019 Oct; 24(8):982-991. PubMed ID: 31107131
[TBL] [Abstract][Full Text] [Related]
5. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
Boche M; Pokharkar V
AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification.
Pan L; Zhou J; Ju F; Zhu H
Drug Deliv Transl Res; 2018 Feb; 8(1):83-96. PubMed ID: 29134552
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
10. Osthole-Loaded Nanoemulsion Enhances Brain Target in the Treatment of Alzheimer's Disease via Intranasal Administration.
Song Y; Wang X; Wang X; Wang J; Hao Q; Hao J; Hou X
Oxid Med Cell Longev; 2021; 2021():8844455. PubMed ID: 33564364
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement.
Karami Z; Saghatchi Zanjani MR; Rezaee S; Rostamizadeh K; Hamidi M
Drug Dev Ind Pharm; 2019 May; 45(5):736-744. PubMed ID: 30640551
[TBL] [Abstract][Full Text] [Related]
12. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
13. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Alzheimer's diseases using donepezil nanoemulsion: an intranasal approach.
Kaur A; Nigam K; Bhatnagar I; Sukhpal H; Awasthy S; Shankar S; Tyagi A; Dang S
Drug Deliv Transl Res; 2020 Dec; 10(6):1862-1875. PubMed ID: 32297166
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
16. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,
Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S
Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
Jojo GM; Kuppusamy G; De A; Karri VVSNR
Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
[TBL] [Abstract][Full Text] [Related]
19. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
Iqbal R; Ahmed S; Jain GK; Vohora D
Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model.
Gaba B; Khan T; Haider MF; Alam T; Baboota S; Parvez S; Ali J
Biomed Res Int; 2019; 2019():2382563. PubMed ID: 31111044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
